Subscribe
shutterstock_796969141_hotaik_sung
Hotaik Sung / Shutterstock.com
11 July 2019AmericasSarah Morgan

Fed Circuit rejects Stanford DNA test appeal

The US Court of Appeals for the Federal Circuit yesterday, July 10, handed victory to researchers at the Chinese University of Hong Kong (CUHK) in a case involving a foetal testing patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Fed Circ. affirms Stanford genetics patent rejection
26 March 2021   The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Genetics
23andMe petitions Fed Circuit for en banc review
8 November 2019   DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
Americas
Federal Circuit vacates PTAB’s decision on foetal testing patent
28 June 2017   The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
Fed Circ. affirms Stanford genetics patent rejection
26 March 2021   The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Genetics
23andMe petitions Fed Circuit for en banc review
8 November 2019   DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
Americas
Federal Circuit vacates PTAB’s decision on foetal testing patent
28 June 2017   The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.

More on this story

Americas
Fed Circ. affirms Stanford genetics patent rejection
26 March 2021   The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Genetics
23andMe petitions Fed Circuit for en banc review
8 November 2019   DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
Americas
Federal Circuit vacates PTAB’s decision on foetal testing patent
28 June 2017   The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB